InsidersTradesSigma
Browse the detailed record of transactions filed by Breber Sandra, Chief Executive Officer. Director active across 2 companies, notably Augmedix, Inc.. Cumulatively, 2 disclosures have been published. Total volume traded: €86k. The latest transaction was disclosed on 28 October 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
Sandra Breber is the Chief Operating Officer at Augmedix, Inc. She is responsible for managing operations and implementing growth strategies. Her role is essential for ensuring the company's efficiency and profitability.